 | • レポートコード：GIR-107A14310 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、89ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、膵島アミロイドポリペプチドのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。膵島アミロイドポリペプチドの種類別市場規模（AC-253、DACRA-042、DACRA-089、KBP-056、KBP-088、その他）、用途別市場規模（代謝障害、胃腸障害、筋骨格系障害、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・膵島アミロイドポリペプチドの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Adocia SAS、AstraZeneca Plc、Eli Lilly and Co、Neurimmune Holding AG、Nordic Bioscience A/S、Prothena Corp Plc、reMYND NV、Zealand Pharma AS ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：AC-253、DACRA-042、DACRA-089、KBP-056、KBP-088、その他 ・用途別分析2016年-2026年：代謝障害、胃腸障害、筋骨格系障害、その他 ・膵島アミロイドポリペプチドの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・膵島アミロイドポリペプチドのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・膵島アミロイドポリペプチドのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・膵島アミロイドポリペプチドの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・膵島アミロイドポリペプチドの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Islet Amyloid Polypeptide market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Islet Amyloid Polypeptide size is estimated to be xx million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global Islet Amyloid Polypeptide market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Islet Amyloid Polypeptide market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
AC-253
DACRA-042
DACRA-089
KBP-056
KBP-088
Others
Market segment by Application can be divided into
Metabolic Disorders
Gastrointestinal
Musculoskeletal Disorders
Others
The key market players for global Islet Amyloid Polypeptide market are listed below:
Adocia SAS
AstraZeneca Plc
Eli Lilly and Co
Neurimmune Holding AG
Nordic Bioscience A/S
Prothena Corp Plc
reMYND NV
Zealand Pharma AS
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Islet Amyloid Polypeptide product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Islet Amyloid Polypeptide, with price, sales, revenue and global market share of Islet Amyloid Polypeptide from 2019 to 2021.
Chapter 3, the Islet Amyloid Polypeptide competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Islet Amyloid Polypeptide breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Islet Amyloid Polypeptide market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Islet Amyloid Polypeptide sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Islet Amyloid Polypeptide Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Islet Amyloid Polypeptide Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 AC-253
1.2.3 DACRA-042
1.2.4 DACRA-089
1.2.5 KBP-056
1.2.6 KBP-088
1.2.7 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Islet Amyloid Polypeptide Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Metabolic Disorders
1.3.3 Gastrointestinal
1.3.4 Musculoskeletal Disorders
1.3.5 Others
1.4 Global Islet Amyloid Polypeptide Market Size & Forecast
1.4.1 Global Islet Amyloid Polypeptide Sales in Value (2016-2026))
1.4.2 Global Islet Amyloid Polypeptide Sales in Volume (2016-2026)
1.4.3 Global Islet Amyloid Polypeptide Price by Type (2016-2026) & (USD/Pcs)
1.5 Global Islet Amyloid Polypeptide Production Capacity Analysis
1.5.1 Global Islet Amyloid Polypeptide Total Production Capacity (2016-2026)
1.5.2 Global Islet Amyloid Polypeptide Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Islet Amyloid Polypeptide Market Drivers
1.6.2 Islet Amyloid Polypeptide Market Restraints
1.6.3 Islet Amyloid Polypeptide Trends Analysis
2 Manufacturers Profiles
2.1 Adocia SAS
2.1.1 Adocia SAS Details
2.1.2 Adocia SAS Major Business
2.1.3 Adocia SAS Islet Amyloid Polypeptide Product and Services
2.1.4 Adocia SAS Islet Amyloid Polypeptide Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 AstraZeneca Plc
2.2.1 AstraZeneca Plc Details
2.2.2 AstraZeneca Plc Major Business
2.2.3 AstraZeneca Plc Islet Amyloid Polypeptide Product and Services
2.2.4 AstraZeneca Plc Islet Amyloid Polypeptide Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Eli Lilly and Co
2.3.1 Eli Lilly and Co Details
2.3.2 Eli Lilly and Co Major Business
2.3.3 Eli Lilly and Co Islet Amyloid Polypeptide Product and Services
2.3.4 Eli Lilly and Co Islet Amyloid Polypeptide Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Neurimmune Holding AG
2.4.1 Neurimmune Holding AG Details
2.4.2 Neurimmune Holding AG Major Business
2.4.3 Neurimmune Holding AG Islet Amyloid Polypeptide Product and Services
2.4.4 Neurimmune Holding AG Islet Amyloid Polypeptide Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Nordic Bioscience A/S
2.5.1 Nordic Bioscience A/S Details
2.5.2 Nordic Bioscience A/S Major Business
2.5.3 Nordic Bioscience A/S Islet Amyloid Polypeptide Product and Services
2.5.4 Nordic Bioscience A/S Islet Amyloid Polypeptide Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 Prothena Corp Plc
2.6.1 Prothena Corp Plc Details
2.6.2 Prothena Corp Plc Major Business
2.6.3 Prothena Corp Plc Islet Amyloid Polypeptide Product and Services
2.6.4 Prothena Corp Plc Islet Amyloid Polypeptide Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 reMYND NV
2.7.1 reMYND NV Details
2.7.2 reMYND NV Major Business
2.7.3 reMYND NV Islet Amyloid Polypeptide Product and Services
2.7.4 reMYND NV Islet Amyloid Polypeptide Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 Zealand Pharma AS
2.8.1 Zealand Pharma AS Details
2.8.2 Zealand Pharma AS Major Business
2.8.3 Zealand Pharma AS Islet Amyloid Polypeptide Product and Services
2.8.4 Zealand Pharma AS Islet Amyloid Polypeptide Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Islet Amyloid Polypeptide Sales by Manufacturer
3.1 Global Islet Amyloid Polypeptide Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Islet Amyloid Polypeptide Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Islet Amyloid Polypeptide
3.4 Market Concentration Rate
3.4.1 Top 3 Islet Amyloid Polypeptide Manufacturer Market Share
3.4.2 Top 6 Islet Amyloid Polypeptide Manufacturer Market Share
3.5 Global Islet Amyloid Polypeptide Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Islet Amyloid Polypeptide Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Islet Amyloid Polypeptide Market Size by Region
4.1.1 Global Islet Amyloid Polypeptide Sales in Volume by Region (2016-2026)
4.1.2 Global Islet Amyloid Polypeptide Revenue by Region (2016-2026)
4.2 North America Islet Amyloid Polypeptide Revenue (2016-2026)
4.3 Europe Islet Amyloid Polypeptide Revenue (2016-2026)
4.4 Asia-Pacific Islet Amyloid Polypeptide Revenue (2016-2026)
4.5 South America Islet Amyloid Polypeptide Revenue (2016-2026)
4.6 Middle East and Africa Islet Amyloid Polypeptide Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Islet Amyloid Polypeptide Sales in Volume by Type (2016-2026)
5.2 Global Islet Amyloid Polypeptide Revenue by Type (2016-2026)
5.3 Global Islet Amyloid Polypeptide Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Islet Amyloid Polypeptide Sales in Volume by Application (2016-2026)
6.2 Global Islet Amyloid Polypeptide Revenue by Application (2016-2026)
6.3 Global Islet Amyloid Polypeptide Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Islet Amyloid Polypeptide Sales by Type (2016-2026)
7.2 North America Islet Amyloid Polypeptide Sales by Application (2016-2026)
7.3 North America Islet Amyloid Polypeptide Market Size by Country
7.3.1 North America Islet Amyloid Polypeptide Sales in Volume by Country (2016-2026)
7.3.2 North America Islet Amyloid Polypeptide Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Islet Amyloid Polypeptide Sales by Type (2016-2026)
8.2 Europe Islet Amyloid Polypeptide Sales by Application (2016-2026)
8.3 Europe Islet Amyloid Polypeptide Market Size by Country
8.3.1 Europe Islet Amyloid Polypeptide Sales in Volume by Country (2016-2026)
8.3.2 Europe Islet Amyloid Polypeptide Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Islet Amyloid Polypeptide Sales by Type (2016-2026)
9.2 Asia-Pacific Islet Amyloid Polypeptide Sales by Application (2016-2026)
9.3 Asia-Pacific Islet Amyloid Polypeptide Market Size by Region
9.3.1 Asia-Pacific Islet Amyloid Polypeptide Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Islet Amyloid Polypeptide Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Islet Amyloid Polypeptide Sales by Type (2016-2026)
10.2 South America Islet Amyloid Polypeptide Sales by Application (2016-2026)
10.3 South America Islet Amyloid Polypeptide Market Size by Country
10.3.1 South America Islet Amyloid Polypeptide Sales in Volume by Country (2016-2026)
10.3.2 South America Islet Amyloid Polypeptide Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Islet Amyloid Polypeptide Sales by Type (2016-2026)
11.2 Middle East & Africa Islet Amyloid Polypeptide Sales by Application (2016-2026)
11.3 Middle East & Africa Islet Amyloid Polypeptide Market Size by Country
11.3.1 Middle East & Africa Islet Amyloid Polypeptide Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Islet Amyloid Polypeptide Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Islet Amyloid Polypeptide Typical Distributors
12.3 Islet Amyloid Polypeptide Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Islet Amyloid Polypeptide Revenue by Type, (USD Million), 2021-2026
Table 2. Global Islet Amyloid Polypeptide Revenue by Application, (USD Million), 2021-2026
Table 3. Adocia SAS Basic Information, Manufacturing Base and Competitors
Table 4. Adocia SAS Major Business
Table 5. Adocia SAS Islet Amyloid Polypeptide Product and Services
Table 6. Adocia SAS Islet Amyloid Polypeptide Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. AstraZeneca Plc Basic Information, Manufacturing Base and Competitors
Table 8. AstraZeneca Plc Major Business
Table 9. AstraZeneca Plc Islet Amyloid Polypeptide Product and Services
Table 10. AstraZeneca Plc Islet Amyloid Polypeptide Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Eli Lilly and Co Basic Information, Manufacturing Base and Competitors
Table 12. Eli Lilly and Co Major Business
Table 13. Eli Lilly and Co Islet Amyloid Polypeptide Product and Services
Table 14. Eli Lilly and Co Islet Amyloid Polypeptide Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Neurimmune Holding AG Basic Information, Manufacturing Base and Competitors
Table 16. Neurimmune Holding AG Major Business
Table 17. Neurimmune Holding AG Islet Amyloid Polypeptide Product and Services
Table 18. Neurimmune Holding AG Islet Amyloid Polypeptide Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Nordic Bioscience A/S Basic Information, Manufacturing Base and Competitors
Table 20. Nordic Bioscience A/S Major Business
Table 21. Nordic Bioscience A/S Islet Amyloid Polypeptide Product and Services
Table 22. Nordic Bioscience A/S Islet Amyloid Polypeptide Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Prothena Corp Plc Basic Information, Manufacturing Base and Competitors
Table 24. Prothena Corp Plc Major Business
Table 25. Prothena Corp Plc Islet Amyloid Polypeptide Product and Services
Table 26. Prothena Corp Plc Islet Amyloid Polypeptide Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. reMYND NV Basic Information, Manufacturing Base and Competitors
Table 28. reMYND NV Major Business
Table 29. reMYND NV Islet Amyloid Polypeptide Product and Services
Table 30. reMYND NV Islet Amyloid Polypeptide Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Zealand Pharma AS Basic Information, Manufacturing Base and Competitors
Table 32. Zealand Pharma AS Major Business
Table 33. Zealand Pharma AS Islet Amyloid Polypeptide Product and Services
Table 34. Zealand Pharma AS Islet Amyloid Polypeptide Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Global Islet Amyloid Polypeptide Sales by Manufacturer (2019-2021e) & (K Pcs)
Table 36. Global Islet Amyloid Polypeptide Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 37. Market Position of Manufacturers in Islet Amyloid Polypeptide, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 38. Global Islet Amyloid Polypeptide Production Capacity by Company, (K Pcs): 2020 VS 2021
Table 39. Head Office and Islet Amyloid Polypeptide Production Site of Key Manufacturer
Table 40. Islet Amyloid Polypeptide New Entrant and Capacity Expansion Plans
Table 41. Islet Amyloid Polypeptide Mergers & Acquisitions in the Past Five Years
Table 42. Global Islet Amyloid Polypeptide Sales by Region (2016-2021e) & (K Pcs)
Table 43. Global Islet Amyloid Polypeptide Sales by Region (2021-2026) & (K Pcs)
Table 44. Global Islet Amyloid Polypeptide Revenue by Region (2016-2021e) & (USD Million)
Table 45. Global Islet Amyloid Polypeptide Revenue by Region (2021-2026) & (USD Million)
Table 46. Global Islet Amyloid Polypeptide Sales by Type (2016-2021e) & (K Pcs)
Table 47. Global Islet Amyloid Polypeptide Sales by Type (2021-2026) & (K Pcs)
Table 48. Global Islet Amyloid Polypeptide Revenue by Type (2016-2021e) & (USD Million)
Table 49. Global Islet Amyloid Polypeptide Revenue by Type (2021-2026) & (USD Million)
Table 50. Global Islet Amyloid Polypeptide Price by Type (2016-2021e) & (USD/Pcs)
Table 51. Global Islet Amyloid Polypeptide Price by Type (2021-2026) & (USD/Pcs)
Table 52. Global Islet Amyloid Polypeptide Sales by Application (2016-2021e) & (K Pcs)
Table 53. Global Islet Amyloid Polypeptide Sales by Application (2021-2026) & (K Pcs)
Table 54. Global Islet Amyloid Polypeptide Revenue by Application (2016-2021e) & (USD Million)
Table 55. Global Islet Amyloid Polypeptide Revenue by Application (2021-2026) & (USD Million)
Table 56. Global Islet Amyloid Polypeptide Price by Application (2016-2021e) & (USD/Pcs)
Table 57. Global Islet Amyloid Polypeptide Price by Application (2021-2026) & (USD/Pcs)
Table 58. North America Islet Amyloid Polypeptide Sales by Country (2016-2021e) & (K Pcs)
Table 59. North America Islet Amyloid Polypeptide Sales by Country (2021-2026) & (K Pcs)
Table 60. North America Islet Amyloid Polypeptide Revenue by Country (2016-2021e) & (USD Million)
Table 61. North America Islet Amyloid Polypeptide Revenue by Country (2021-2026) & (USD Million)
Table 62. North America Islet Amyloid Polypeptide Sales by Type (2016-2021e) & (K Pcs)
Table 63. North America Islet Amyloid Polypeptide Sales by Type (2021-2026) & (K Pcs)
Table 64. North America Islet Amyloid Polypeptide Sales by Application (2016-2021e) & (K Pcs)
Table 65. North America Islet Amyloid Polypeptide Sales by Application (2021-2026) & (K Pcs)
Table 66. Europe Islet Amyloid Polypeptide Sales by Country (2016-2021e) & (K Pcs)
Table 67. Europe Islet Amyloid Polypeptide Sales by Country (2021-2026) & (K Pcs)
Table 68. Europe Islet Amyloid Polypeptide Revenue by Country (2016-2021e) & (USD Million)
Table 69. Europe Islet Amyloid Polypeptide Revenue by Country (2021-2026) & (USD Million)
Table 70. Europe Islet Amyloid Polypeptide Sales by Type (2016-2021e) & (K Pcs)
Table 71. Europe Islet Amyloid Polypeptide Sales by Type (2021-2026) & (K Pcs)
Table 72. Europe Islet Amyloid Polypeptide Sales by Application (2016-2021e) & (K Pcs)
Table 73. Europe Islet Amyloid Polypeptide Sales by Application (2021-2026) & (K Pcs)
Table 74. Asia-Pacific Islet Amyloid Polypeptide Sales by Region (2016-2021e) & (K Pcs)
Table 75. Asia-Pacific Islet Amyloid Polypeptide Sales by Region (2021-2026) & (K Pcs)
Table 76. Asia-Pacific Islet Amyloid Polypeptide Revenue by Region (2016-2021e) & (USD Million)
Table 77. Asia-Pacific Islet Amyloid Polypeptide Revenue by Region (2021-2026) & (USD Million)
Table 78. Asia-Pacific Islet Amyloid Polypeptide Sales by Type (2016-2021e) & (K Pcs)
Table 79. Asia-Pacific Islet Amyloid Polypeptide Sales by Type (2021-2026) & (K Pcs)
Table 80. Asia-Pacific Islet Amyloid Polypeptide Sales by Application (2016-2021e) & (K Pcs)
Table 81. Asia-Pacific Islet Amyloid Polypeptide Sales by Application (2021-2026) & (K Pcs)
Table 82. South America Islet Amyloid Polypeptide Sales by Country (2016-2021e) & (K Pcs)
Table 83. South America Islet Amyloid Polypeptide Sales by Country (2021-2026) & (K Pcs)
Table 84. South America Islet Amyloid Polypeptide Revenue by Country (2016-2021e) & (USD Million)
Table 85. South America Islet Amyloid Polypeptide Revenue by Country (2021-2026) & (USD Million)
Table 86. South America Islet Amyloid Polypeptide Sales by Type (2016-2021e) & (K Pcs)
Table 87. South America Islet Amyloid Polypeptide Sales by Type (2021-2026) & (K Pcs)
Table 88. South America Islet Amyloid Polypeptide Sales by Application (2016-2021e) & (K Pcs)
Table 89. South America Islet Amyloid Polypeptide Sales by Application (2021-2026) & (K Pcs)
Table 90. Middle East & Africa Islet Amyloid Polypeptide Sales by Country (2016-2021e) & (K Pcs)
Table 91. Middle East & Africa Islet Amyloid Polypeptide Sales by Country (2021-2026) & (K Pcs)
Table 92. Middle East & Africa Islet Amyloid Polypeptide Revenue by Country (2016-2021e) & (USD Million)
Table 93. Middle East & Africa Islet Amyloid Polypeptide Revenue by Country (2021-2026) & (USD Million)
Table 94. Middle East & Africa Islet Amyloid Polypeptide Sales by Type (2016-2021e) & (K Pcs)
Table 95. Middle East & Africa Islet Amyloid Polypeptide Sales by Type (2021-2026) & (K Pcs)
Table 96. Middle East & Africa Islet Amyloid Polypeptide Sales by Application (2016-2021e) & (K Pcs)
Table 97. Middle East & Africa Islet Amyloid Polypeptide Sales by Application (2021-2026) & (K Pcs)
Table 98. Direct Channel Pros & Cons
Table 99. Indirect Channel Pros & Cons
Table 100. Islet Amyloid Polypeptide Typical Distributors
Table 101. Islet Amyloid Polypeptide Typical Customers
List of Figures
Figure 1. Islet Amyloid Polypeptide Picture
Figure 2. Global Islet Amyloid Polypeptide Sales Market Share by Type in 2020
Figure 3. AC-253
Figure 4. DACRA-042
Figure 5. DACRA-089
Figure 6. KBP-056
Figure 7. KBP-088
Figure 8. Others
Figure 9. Global Islet Amyloid Polypeptide Sales Market Share by Application in 2020
Figure 10. Metabolic Disorders
Figure 11. Gastrointestinal
Figure 12. Musculoskeletal Disorders
Figure 13. Others
Figure 14. Global Islet Amyloid Polypeptide Market Size, (USD Million) & (K Pcs): 2020 VS 2021 VS 2026
Figure 15. Global Islet Amyloid Polypeptide Market Size and Forecast (2016-2026) & (USD Million)
Figure 16. Global Islet Amyloid Polypeptide Sales (2016-2026) & (K Pcs)
Figure 17. Global Islet Amyloid Polypeptide Price by Type (2016-2026) & (USD/Pcs)
Figure 18. Global Islet Amyloid Polypeptide Production Capacity (2016-2026) & (K Pcs)
Figure 19. Global Islet Amyloid Polypeptide Production Capacity by Geographic Region: 2020 VS 2021
Figure 20. Islet Amyloid Polypeptide Market Drivers
Figure 21. Islet Amyloid Polypeptide Market Restraints
Figure 22. Islet Amyloid Polypeptide Market Trends
Figure 23. Global Islet Amyloid Polypeptide Sales Market Share by Manufacturer in 2020
Figure 24. Global Islet Amyloid Polypeptide Revenue Market Share by Manufacturer in 2020
Figure 25. Islet Amyloid Polypeptide Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 26. Top 3 Islet Amyloid Polypeptide Manufacturer (Revenue) Market Share in 2020
Figure 27. Top 6 Islet Amyloid Polypeptide Manufacturer (Revenue) Market Share in 2020
Figure 28. Global Islet Amyloid Polypeptide Sales Market Share by Region (2016-2026)
Figure 29. Global Islet Amyloid Polypeptide Revenue Market Share by Region (2016-2026)
Figure 30. North America Islet Amyloid Polypeptide Revenue (2016-2026) & (USD Million)
Figure 31. Europe Islet Amyloid Polypeptide Revenue (2016-2026) & (USD Million)
Figure 32. Asia-Pacific Islet Amyloid Polypeptide Revenue (2016-2026) & (USD Million)
Figure 33. South America Islet Amyloid Polypeptide Revenue (2016-2026) & (USD Million)
Figure 34. Middle East & Africa Islet Amyloid Polypeptide Revenue (2016-2026) & (USD Million)
Figure 35. Global Islet Amyloid Polypeptide Sales Market Share by Type (2016-2026)
Figure 36. Global Islet Amyloid Polypeptide Revenue Market Share by Type (2016-2026)
Figure 37. Global Islet Amyloid Polypeptide Price by Type (2016-2026) & (USD/Pcs)
Figure 38. Global Islet Amyloid Polypeptide Sales Market Share by Application (2016-2026)
Figure 39. Global Islet Amyloid Polypeptide Revenue Market Share by Application (2016-2026)
Figure 40. Global Islet Amyloid Polypeptide Price by Application (2016-2026) & (USD/Pcs)
Figure 41. North America Islet Amyloid Polypeptide Sales Market Share by Type (2016-2026)
Figure 42. North America Islet Amyloid Polypeptide Sales Market Share by Application (2016-2026)
Figure 43. North America Islet Amyloid Polypeptide Sales Market Share by Country (2016-2026)
Figure 44. North America Islet Amyloid Polypeptide Revenue Market Share by Country (2016-2026)
Figure 45. United States Islet Amyloid Polypeptide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Canada Islet Amyloid Polypeptide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Mexico Islet Amyloid Polypeptide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. Europe Islet Amyloid Polypeptide Sales Market Share by Type (2016-2026)
Figure 49. Europe Islet Amyloid Polypeptide Sales Market Share by Application (2016-2026)
Figure 50. Europe Islet Amyloid Polypeptide Sales Market Share by Country (2016-2026)
Figure 51. Europe Islet Amyloid Polypeptide Revenue Market Share by Country (2016-2026)
Figure 52. Germany Islet Amyloid Polypeptide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. France Islet Amyloid Polypeptide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. United Kingdom Islet Amyloid Polypeptide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Russia Islet Amyloid Polypeptide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Italy Islet Amyloid Polypeptide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Asia-Pacific Islet Amyloid Polypeptide Sales Market Share by Region (2016-2026)
Figure 58. Asia-Pacific Islet Amyloid Polypeptide Sales Market Share by Application (2016-2026)
Figure 59. Asia-Pacific Islet Amyloid Polypeptide Sales Market Share by Region (2016-2026)
Figure 60. Asia-Pacific Islet Amyloid Polypeptide Revenue Market Share by Region (2016-2026)
Figure 61. China Islet Amyloid Polypeptide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Japan Islet Amyloid Polypeptide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Korea Islet Amyloid Polypeptide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. India Islet Amyloid Polypeptide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Southeast Asia Islet Amyloid Polypeptide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Australia Islet Amyloid Polypeptide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. South America Islet Amyloid Polypeptide Sales Market Share by Type (2016-2026)
Figure 68. South America Islet Amyloid Polypeptide Sales Market Share by Application (2016-2026)
Figure 69. South America Islet Amyloid Polypeptide Sales Market Share by Country (2016-2026)
Figure 70. South America Islet Amyloid Polypeptide Revenue Market Share by Country (2016-2026)
Figure 71. Brazil Islet Amyloid Polypeptide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Argentina Islet Amyloid Polypeptide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Middle East & Africa Islet Amyloid Polypeptide Sales Market Share by Type (2016-2026)
Figure 74. Middle East & Africa Islet Amyloid Polypeptide Sales Market Share by Application (2016-2026)
Figure 75. Middle East & Africa Islet Amyloid Polypeptide Sales Market Share by Country (2016-2026)
Figure 76. Middle East & Africa Islet Amyloid Polypeptide Revenue Market Share by Country (2016-2026)
Figure 77. Turkey Islet Amyloid Polypeptide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. Egypt Islet Amyloid Polypeptide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. Saudi Arabia Islet Amyloid Polypeptide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 80. South Africa Islet Amyloid Polypeptide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 81. Sales Channel: Direct Channel vs Indirect Channel
Figure 82. Methodology
Figure 83. Research Process and Data Source
世界の胃抑制性ポリペプチド受容体市場 2021：企業別、地域別、種類・用途別 The Gastric Inhibitory Polypeptide Receptor market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizatio…- 合成ポリペプチド薬の世界市場… Scope of the Report: The worldwide market for Synthesis Polypeptide Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Synthesis P…
- 世界の破壊的行動障害市場 2021：企業別、地域別、種類・用途別 The Disruptive Behavior Disorders market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade r…
- 世界の中枢神経系疾患用遺伝子治療市場 2021：企業別、地域別、種類・用途別 The Gene Therapy for CNS Disorders market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade …
- 世界の皮膚疾患治療薬市場 2021：企業別、地域別、種類・用途別 The Dermatological Disorders Medications market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, …